Abstracts
Showing 851 abstracts.
Citation
Mark Mirochnick, Brookie Best, Angela Kashuba, Craig Sykes, Amanda Schauer, JiaJia Wang, Alice Stek, Elizabeth Smith, Nahida Chakhtoura, Edmund Capparelli. Rilpivirine Female Genital Tract Concentrations in Pregnant and Postpartum Women. Presented at: CROI 2016; 2016 Feb 24.Conference
CROI 2016
Study
P1026S
Citation
Nikki Mulligan, Brookie Best, Edmund Capparelli, Alice Stek, Emily Barr, Elizabeth Smith, Nahida Chakhtoura, JiaJia Wang, Sandra Burchett, Mark Mirochnick. Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Postpartum Women. Presented at: CROI 2016; 2016 Feb 24.Conference
CROI 2016
Study
P1026S
Citation
Priyanka Uprety, Jane Lindsey, Myron Levin, Kaitlin Rainwater-Lovett, Carrie Ziemniak, MERCK#1, MERCK#2, P1072#4, Adriana Weinberg, Deborah Persaud. Enhanced Inflammation and Rotavirus Vaccine Responses in Perinatal HIV-1 Infection. Presented at: CROI 2016; 2016 Feb 23.Conference
CROI 2016
Study
P1072
Citation
GK Siberry, C Tierney , L Stranix-Chibanda, C Marr, JA Shepherd, R Browning, H Kalkwarf, K George, MG Fowler for the IMPAACT P1084s team. Impact of maternal tenofovir use on HIV exposed newborn bone mineral. Presented at: CROI 2016; 2016 Feb 23.Conference
CROI 2016
Study
P1084s
Citation
P Uprety , K Patel, B Karalius, K Rainwatr-Lovett, C Ziemniak, Y Chen, S Siminski, R Van Dyke, G Seage, D Persaud. HIV-1 Dynamics over a decade or more of Viral Suppression in Perinatal Infection. Presented at: CROI 2016; 2016 Feb 24.Conference
CROI 2016
Citation
E Nemes, A Toefy, A Penn-Nicholson, J Hughes, M DeKock, T Scriba, M Hatherill, W Hanekom, M Cameron, M Cotton, S Pahwa and the IMPAACT P1073 team. Host Correlates of Risk of Bacille Calmette-Guerin (BCG) Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV+ Children Starting Antiretroviral Therapy (ART). Presented at: IAS 2016.Conference
IAS 2016
Study
P1073
Citation
Stein Schalkwijk, Rob ter Heine, Angela Colbers, Alwin Huitema, Palolo Denti, Kelly Dooley, Edmund Capparelli, Brookie Best, Tim Cressey, Rick Greupink, Frans Russel, Mark Mirochnick, David Burger. Pregnancy: a barrier to dose reduction of efavirenz?. Presented at: CROI 2016.Conference
CROI 2016
Study
P1026S
Citation
Michael Biovin, Miriam Chernoff, Bonnie Zimmer, Barbara Laughton, Celeste Joyce, Katie McCarthy, Pim Brouwers, Patrick Jean-Philippe, Sonia Lee, Joan Coetzee, Avy Violari, Mark Cotton, Paul Palumbo, P1104s Study Team. Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial is poorer than non-infected children at those study sites. Presented at: 8th International Workshop on HIV Pediatrics; 2016 Jul 16.Conference
8th International Workshop on HIV Pediatrics
Study
P1104s
Citation
Jos Lommerse, Diana Clarke, Anne Chain, Han Wities, Hedy Teppler, Edward Acosta, Edmund Capparelli, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector , Betsy Smith, Mark Mirochnick. Raltegravir PK in neonates– An adaptive trial design to define an appropriate regimen for neonates from birth to 6 weeks of age. Presented at: American Conference on Pharmacometrics (ACoP).Conference
American Conference on Pharmacometrics (ACoP)
Study
P1110
Citation
Jos Lommerse, Diana Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edward P Acosta, Edmund Capparelli, Matthew L. Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector, Betsy Smith, Mark Mirochnick. Raltegravir PK in neonates – Modeling rising and declining PK profiles of newborns exposed to raltegravir in-utero. Presented at: American Conference on Pharmacometrics (ACoP).Conference
American Conference on Pharmacometrics (ACoP)
Study
P1097